Homepage
Medication Guide
Side Effects of Capivasertib
Capivasertib is a next-generation AKT kinase inhibitor. Used in combination with fulvestrant, it treats HR-positive, HER2-negative advanced breast cancer harboring PIK3CA/AKT1/PTEN mutations. While de...
502
Thursday, December 4th, 2025, 10:45
What Are the Precautions for Capivasertib Administration?
Capivasertib is a kinase inhibitor. It is used in combination with fulvestrant for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer harboring PIK3CA/AKT1/PTEN gene muta...
507
Thursday, December 4th, 2025, 10:42
Dosage and Administration of Capivasertib
Capivasertib is a novel kinase inhibitor that received its first approval in the United States in 2023. As a precision therapy targeting specific gene mutations, it has demonstrated favorable efficacy...
508
Thursday, December 4th, 2025, 10:05
What Are the Indications of Capivasertib?
Capivasertib is a kinase inhibitor developed by AstraZeneca, which was first approved for marketing in the United States in 2023. When used in combination with fulvestrant, this medication is indicate...
503
Wednesday, December 3rd, 2025, 10:27
What Are the Purchase Channels for Capivasertib?
Capivasertib is an AKT kinase inhibitor, providing a new treatment option for patients with HR-positive, HER2-negative advanced breast cancer. As a prescription medication, understanding its standardi...
505
Wednesday, December 3rd, 2025, 10:22
How to Purchase Adempas (Riociguat Tablets)
Adempas (Riociguat Tablets) is a soluble guanylate cyclase stimulant, primarily indicated for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension...
503
Wednesday, December 3rd, 2025, 09:40
Dosage and Administration of Crizotinib
Crizotinib is a multi-target tyrosine kinase inhibitor, primarily indicated for the treatment of ALK-positive or ROS1-positive non-small cell lung cancer (NSCLC), ALK-positive anaplastic large cell ly...
504
Wednesday, December 3rd, 2025, 09:34
Dosage and Administration of Relugolix
Relugolix is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, often formulated as a fixed-dose combination with estrogens (e.g., estradiol) and progestogens (e.g., norethindrone acet...
507
Wednesday, December 3rd, 2025, 09:30
What Are the Purchase Channels for Relugolix?
Relugolix is an innovative gonadotropin-releasing hormone (GnRH) receptor antagonist, which has shown significant efficacy in the treatment of heavy menstrual bleeding associated with uterine fibroids...
507
Wednesday, December 3rd, 2025, 09:27
Precautions for Adagrasib Administration
Adagrasib is an irreversible inhibitor of KRASG12C, primarily indicated for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) with KRASG12C...
504
Wednesday, December 3rd, 2025, 09:25
30 / 200
1994 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved